CUBIST PHARMACEUTICALS INC - NOTE 2.500%11/0

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Debt / NOTE 2.500%11/0
Market price (% of par)
243.2%
Total 13F principal
$200,122,018
Principal change
+$66,000
Total reported market value
$485,995,791
Number of holders
40
Value change
+$161,000
Number of buys
1

Institutional Holders of CUBIST PHARMACEUTICALS INC - NOTE 2.500%11/0 as of Q4 2013

As of 31 Dec 2013, CUBIST PHARMACEUTICALS INC - NOTE 2.500%11/0 was held by 40 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $200,122,018 in principal (par value) of the bond. The largest 10 bondholders included WOLVERINE ASSET MANAGEMENT LLC, BlackRock Advisors LLC, Polar Securities Inc., Whitebox Advisors LLC, BlackRock Institutional Trust Company, N.A., BANK OF AMERICA CORP /DE/, BARCLAYS PLC, BlackRock Group LTD, SSI INVESTMENT MANAGEMENT INC, and DEUTSCHE BANK AG\. This page lists 40 institutional bondholders reporting positions for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.